)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
BioLife Solutions
BioLife Solutions (BLFS) investor relations material
BioLife Solutions has been acquired by Repligen Corporation
BioLife Solutions EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary5 Oct, 2026
Opening remarks and agenda
Meeting called to order on October 5, 2026; September 3, 2026 was the record date, and a quorum was declared.
48,923,333 common shares were outstanding and entitled to vote; at least 16,307,778 shares, one-third of the total, were represented in person virtually or by proxy.
Polls closed at 9:06 A.M. Eastern Time after stockholders had the opportunity to vote online or by proxy.
Specific resolutions to be voted on
Proposal 1 sought adoption of the July 21, 2026 merger agreement with Repligen and the two merger subsidiaries.
Proposal 2 sought non-binding approval of merger-related compensation for named executive officers.
Proposal 3 sought approval to adjourn the meeting if needed, including to solicit additional merger-agreement proxies.
Board and executive committee updates
The board unanimously recommended voting in favor of all three proposals.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BioLife Solutions
- Shareholders to vote on a merger offering cash and stock, amid litigation and executive payouts.BLFS
Proxy filing - Shareholders to vote on merger with Repligen, receiving cash and stock for each share held.BLFSProxy filing
- BioLife stockholders to receive cash and Repligen shares in a board-recommended merger expected to close in Q4 2026.BLFSProxy filing
- Q2 2026 revenue rose 21%, net income surged on a tax benefit, and a $1.5B merger is pending.BLFSQ2 2026
- Strong growth and high margins driven by leadership in cell therapy biopreservation tools.BLFSInvestor presentation
- Q1 2026 revenue grew 25% to $27.5M, with $1.2M net income and reaffirmed 2026 guidance.BLFSQ1 2026
- Achieved $96M revenue and 65% gross margin in FY 2025, driving growth in cell therapy tools.BLFSInvestor presentation
- 2025 revenue rose 29% with margin gains; 2026 guidance targets 17–20% growth and profitability.BLFSQ4 2025
- Q1 2025 revenue up 30% year-over-year, with strong margin expansion and robust outlook.BLFSQ1 2025
BioLife Solutions
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
BioLife Solutions Inc is a supplier of biopreservation tools and services for the cell and gene therapy industry. The company offers biopreservation media, freezers, thawing systems, and cloud-connected storage solutions to support the handling of biological materials. It serves biopharmaceutical companies, research institutions, and contract manufacturers. BioLife Solutions Inc is headquartered in Bothell, Washington, and its shares are listed on the NASDAQ.